Browse > Article
http://dx.doi.org/10.7742/jksr.2020.15.1.63

Effects of Gadolinium Contrast agent on Bone Mineral Density Measurement using Dual Energy X-ray Absorptiometry  

Lee, Keun-Ohk (Department of Radiology, Soonchunhyang University Bucheon Hospital)
Lee, Min-Su (Department of Radiology, Soonchunhyang University Bucheon Hospital)
Publication Information
Journal of the Korean Society of Radiology / v.15, no.1, 2021 , pp. 63-70 More about this Journal
Abstract
Radiographic contrast agents are used for diagnostic purposes and are one of the factors affecting measured values in bone density tests. They are absorbed into tissues and have an effect of increasing the measured values of bone density, so they are avoided as much as possible before performing a bone density test. MRI contrast agents, which have different physical properties and mechanisms of action than radiographic contrast agents, are based on gadolinium, a metal element. They have radiopacity characteristics, so MRI are generally performed prior to examination using radiation. The purpose of this study was to investigate the effects of MRI contrast agents on bone mineral density examination using dual energy X-ray absorption. Two types of gadolinium based MRI contrast agents were injected into an acrylic water tank for each volume, and the humanoid spine phantom was inserted and the BMD and T-score from (L1-L4) were analyzed by scanning a total of 30 times, 5 times for each injection type. The average value of the measured total (L1-L4) bone density for each of the two contrast agents was 0.952±0.052, 0.957±0.050, and 0.956±0.05g/㎠, respectively, for the Gadoterate Meglumine component 0mL, 7.5mL and 15mL, when the gadobutrol components were 0mL, 5mL, and 10mL, there was no statistically significant difference at all sites at 0.953±0.001, 0.954±0.001, and 0.945±0.001g/㎠, respectively(p>0.05). The average value of total T-score was -0.46±0.05, -0.4±0, -0.42±0.04 when the Gadoterate Meglumine component was 0mL, 7.5mL and 15mL, respectively. When the Gadobutrol ingredients were 0mL, 5mL and 10mL, there was no statistically significant difference in all areas, with -0.46±0.05, -0.46±0.05, and 0.5±0.00, respectively. In this experiment, the MRI contrast agent was found to have no effect on bone density tests, using the dual-energy X-ray absorption method. There is a limitation in that physical conditions such as kidney and health conditions etc. were not taken into consideration, so further clinical research is expected to be conducted in the future.
Keywords
Dual Energy X-ray Absorptiometry; Bone Mineral Density; Gadolinium; Osteoporosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 S. H. Jeong, S. H. Choi, J. Y. Kim, J. W. Koo, H. J. Kim, J. S. Kim, "Osteopenia and osteoporosis in idiopathic benign positional vertigo", Neurology, Vol. 72, No. 12, pp. 1069-1076, 2009. http://dx.doi.org/10.1212/01.wnl.0000345016.33983.e0   DOI
2 The Korean Society for AIDS, Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-infected Koreans, pp. 4-13, 2015
3 Claus-C. Gluer, "30 years of DXA technology innovations", Bone, Vol. 104, pp. 7-12, 2017. http://dx.doi.org/10.1016/j.bone.2017.05.020   DOI
4 J. A. Kanis, "Diagnosis of osteoporosis and assessment of fracture risk", The Lancet, Vol. 359, No. 9321, pp. 1929-1936, 2002. http://dx.doi.org/10.1016/S0140-6736(02)08761-5   DOI
5 Korean Society of Radiology, Korean Academy of Asthma, Allergy and Clinical Immunology, Korean clinical practice guideline on adverse reactions of injectable iodinated contrast agent and gadolinium contrast agent for MRI. 2nd edition, Korean Society of Radiology, pp. 50-55, 2016.
6 R. M. Lorente Ramos, J. Azpeitia Arman, N. Arevalo Galeano, A. Munoz Hernandez, J. M. Garcia Gomez, J. G. Molinero, "Dual energy X-ray absorptimetry: Fundamentals, methodology, and clinical applications", Radiologia, Vol. 54, No. 5, pp. 410-423, 2012. http://dx.doi.org/10.1016/j.rx.2011.09.023   DOI
7 J. W. Henson, R. G. Nogueira, D. J. Covarrubias, R. G. Gonzalez, M. H. Lev, "Gadolinium-Enhanced CT Angiography of the Circle of Willis and Neck", American Journal of Neuroradiology, Vol. 25, No. 6, pp. 969-972, 2004.
8 C. Chicoskie, R. Tello, "Gadolinium-Enhanced MDCT Angiography of the Abdomen: Feasibility and Limitation", American Journal of Roentgenology, Vol. 184, No. 6, pp.1821-1828, 2005. https://doi.org/10.2214/ajr.184.6.01841821   DOI
9 Y. J. Moon, J. N. Kim, I. J. Kim, H. J. Jeon, "Effect of Radioactive Isotope (99mTc) on Bone Mineral Density Measurement using the Dual Energy X-ray Absorptiometry", The Korean Society of Radiological Imaging Technology, Vol. 15, No. 1, pp. 97-102, 2018. http://scholar.dkyobobook.co.kr/searchDetail.laf?barcode=4010026498837
10 T. Masud, S. Langley, P. Wiltshire, D. V. Doyle, T. D. Spector, "Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis", British Medical Journal, Vol. 307, No. 6897, pp. 172-173, 1993. http://dx.doi.org/10.1136/bmj.307.6897.172   DOI
11 B. Mueller, M. K. O'Connor, "Effects of radioisotopes on the accuracy of dual-energy X-ray absorptiometry for bone densitometry", Journal of clinical densitometry, Vol. 5, No. 3, pp. 283-287, 2002. http://dx.doi.org/10.1385/JCD:5:3:283   DOI
12 W. H. Ju, "The Evaluation of Gadolinium based Contrast Agent as a Substitutive Contrast Agent in Dual Energy X-ray CT", Master's Thesis, Korea University, 2016.3
13 A. Sala, C. Webber, J. Halton, J. Morrison, L. Beaumont, A. Zietak, R. Barr, "Effect of diagnostic radioisotopes and radiographic contrast media on measurements of lumbar spine bone mineral density and body composition by dual-energy x-ray absorptiometry", Journal of Clinical Densitometry, Vol. 9, No. 1, pp. 91-96, 2006. http://dx.doi.org/10.1016/j.jocd.2005.10.003   DOI
14 H. S. Kim, D. K. Dong, "Appropriate image quality management method of bone mineral density measurement", The Korea Contents Association, Vol. 7, No. 1, pp. 1141-1149, 2009.
15 Medical Imaging Research Society, Magnetic resonance imaging, Daihakseorim Publishing., Republic of korea, 2019.